These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9448013)

  • 1. Standardization of prothrombin fragment 1.2 measurement: effects of preanalytical variables and calibrator selection.
    Hursting MJ; Slaughter TF; Stead AG; Szewczyk KM; Witt DJ; Greenberg CS
    Arch Pathol Lab Med; 1998 Jan; 122(1):31-6. PubMed ID: 9448013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination.
    Bruhn HD; Conard J; Mannucci M; Monteagudo J; Pelzer H; Reverter JC; Samama M; Tripodi A; Wagner C
    Thromb Haemost; 1992 Oct; 68(4):413-7. PubMed ID: 1448772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harmonization of commercial ELISA methods for the measurement of prothrombin fragment 1.2: is it feasible?
    D'Angelo A; Della Valle P; Calori G; Galli L; Vigano D'Angelo S
    Thromb Haemost; 1995 Mar; 73(3):548; author reply 549-50. PubMed ID: 7667841
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2.
    Greenberg CS; Hursting MJ; Macik BG; Ortel TL; Kane WH; Moore BM
    Clin Chem; 1994 Oct; 40(10):1962-9. PubMed ID: 7923780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of an enzyme-linked immunosorbent assay for the determination of prothrombin fragment F1.2 (Dade Prothrombin Fragment F1.2 ELISA: Baxter Diagnostics Inc., U.S.A.) using micro-titer plate].
    Suzuki T; Amano K; Kuroso K; Fukutake K; Fujimaki M
    Rinsho Byori; 1993 Feb; 41(2):215-9. PubMed ID: 8361024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor comparability of prothrombin fragment 1 + 2 values measured by two commercial ELISA methods: influence of different anticoagulants and standards.
    Tripodi A; Chantarangkul V; Bottasso B; Mannucci PM
    Thromb Haemost; 1994 May; 71(5):605-8. PubMed ID: 8091388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of prothrombin fragment F1+2 for monitoring the anticoagulant effect of phenprocoumon].
    Bruhn HD; Zurborn KH
    Dtsch Med Wochenschr; 1993 Jul; 118(26):967-70. PubMed ID: 8519230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1 + 2 measurements.
    Bauer KA; Barzegar S; Rosenberg RD
    Thromb Res; 1991 Sep; 63(6):617-28. PubMed ID: 1780806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased left atrial thrombin generation in mitral stenosis is not reflected in arterial prothrombin fragment 1+2 levels.
    Peverill RE; Harper RW; Gan TE; Smolich JJ
    Clin Sci (Lond); 2000 Apr; 98(4):501-6. PubMed ID: 10731487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombophilic variables do not increase the generation or procoagulant activity of thrombin during cardiopulmonary bypass.
    Raivio P; Petäjä J; Kuitunen A; Lassila R
    Ann Thorac Surg; 2008 Feb; 85(2):536-42. PubMed ID: 18222259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of an intravenous intermittent access port (saline lock) for obtaining blood samples for coagulation studies.
    Arrants J; Willis ME; Stevens B; Gripkey L; Herman JA; Hernandez-Brooks L; Eaker JE
    Am J Crit Care; 1999 Sep; 8(5):344-8. PubMed ID: 10467472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombin fragment F1 + 2 concentrations for monitoring anticoagulation therapy with heparin.
    Brack MJ; More RS; Hubner PJ; Gershlick AH
    Int J Cardiol; 1993 Jan; 38(1):57-61. PubMed ID: 8444502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass.
    Philippou H; Adami A; Davidson SJ; Pepper JR; Burman JF; Lane DA
    Thromb Haemost; 2000 Jul; 84(1):124-8. PubMed ID: 10928482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
    Ascani A; Iorio A; Agnelli G
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency.
    Ingerslev J; Holm M; Christiansen K; Knudsen L; Négrier C
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S129-34. PubMed ID: 9819044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.